SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tktrimbath who wrote (379)5/8/2003 6:36:13 PM
From: Mike McFarland of 557
 
These shares have become like call options.
They will trend down slowly over the next
year toward expiring worthless, or will be
diluted severely so that you have to buy new
options. It would be great if TGEN made a
breakthrough before my TGEN 2004 $5 calls
expire. Thanks for the update.

Does Biogen still have an interest in this?
Maybe they'll take out TGEN and save some jobs
--keep a couple of the programs going.

You might want to sign up at that patent server,
Delphion, and browse Tgen's patents, maybe there
is something there of value. A person could compare
the number of patents and type to CEGE and Avigen
for fun.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext